GreenBanana SEO celebrates 30th 5-star Google Review, Reinforcing Role as Best Generative Engine Optimization (GEO) Agency 
The Capital Architect Behind the Gala Robots: Shoucheng Holdings (0697.HK) Enters a Milestone Year of Value Re-rating 
Graphene Manufacturing Group and Tickford Racing Unite to Push Performance Efficiency On and Off the Track Dyne Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
– Initiation of Patient Dosing in Multiple Ascending Dose Clinical Trials for DYNE-251 in DMD…
Aleafia Health to Announce Fiscal Year 2023 First Quarter Results
TORONTO, Aug. 04, 2022 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia…
Altimmune to Report Second Quarter 2022 Financial Results and Provide Business Update on August 11
GAITHERSBURG, Md., Aug. 04, 2022 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical…
BridgeBio Pharma, Inc. Reports Second Quarter 2022 Financial Results and Business Update
– Reported positive interim Phase 2 data for infigratinib in achondroplasia demonstrating a mean increase…
X4 Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Highlights notable upcoming milestones including data from Phase 1b trial in chronic neutropenia, expected in…
Kraig Biocraft Laboratories Posts Behind the Scenes Look into the Laboratory R&D Processes for Creating Recombinant Spider Silk
ANN ARBOR, Mich., Aug. 04, 2022 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB)…
Myriad Genetics Reports Second Quarter Financial Results
Highlights: Revenue of $179.3 million for the quarter ended June 30, 2022 Excluding revenue from divested…
BioCryst Reports Second Quarter 2022 Financial Results and Upcoming Key Milestones
—Q2 2022 ORLADEYO net revenue of $65.2 million— —FY 2022 ORLADEYO net revenue expected to…
Societal CDMO Adds Three New Customers, Signing Agreements to Provide CDMO Services Supporting Clinical Development of Several Novel Therapeutic Candidates
Contracted Activities Touch Upon Broad Range of Societal’s Offerings from Clinical Trial Services to Formulation…
Agios Reports Business Highlights and Second Quarter 2022 Financial Results
– Generated $3.1 Million in Net U.S. Revenue for First Full Quarter of PYRUKYND® (mitapivat)…
Amicus Therapeutics Announces Second Quarter 2022 Financial Results
1H22 Galafold® Revenue of $159.4M, reflecting 11% Sales Growth with Operational Growth of 18%, Partly Offset…
RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO
RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO Combination creates global…
Walden Biosciences Announces Presentation at Canaccord Genuity 42nd Annual Growth Conference
Presentation to highlight transformational approach to treating kidney diseases CAMBRIDGE, Mass., Aug. 04, 2022 (GLOBE…
Breckenridge Distillery and Denver Broncos Release Limited-Edition Mile High Bourbon Blends
America’s Best Blended Whiskey is Back and Better Than Ever Breckenridge x Denver Broncos Mile…
Arvinas Reports Second Quarter 2022 Financial Results and Provides Corporate Update
NEW HAVEN, Conn., Aug. 04, 2022 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage…
COMPASS Pathways plc announces second quarter 2022 financial results and business highlights
LONDON, Aug. 04, 2022 (GLOBE NEWSWIRE) — Highlights: Kabir Nath appointed as Chief Executive Officer…
HOOKIPA Pharma to Report Second Quarter 2022 Financial Results on August 11, 2022
NEW YORK and VIENNA, Austria, Aug. 04, 2022 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ:…
ProQR Announces Second Quarter 2022 Operating and Financial Results
ProQR is accelerating the development of its Axiomer® RNA base-editing technology platform across multiple therapeutic…
iSpecimen Reports Second Quarter 2022 Financial and Operating Results
Enhanced iSpecimen Marketplace® Platform with Data Integration Capabilities to Simplify the Ingestion and Maintenance of…
Orchard Therapeutics Reports Second Quarter 2022 Financial Results and Reviews Recent Business Highlights
Additional Libmeldy® reimbursement discussions advancing across Europe with product sales totaling $3.1M in Q2 and…